DE69811157D1 - Immunoassay zur Bestimmung von PSA-ACT - Google Patents

Immunoassay zur Bestimmung von PSA-ACT

Info

Publication number
DE69811157D1
DE69811157D1 DE69811157T DE69811157T DE69811157D1 DE 69811157 D1 DE69811157 D1 DE 69811157D1 DE 69811157 T DE69811157 T DE 69811157T DE 69811157 T DE69811157 T DE 69811157T DE 69811157 D1 DE69811157 D1 DE 69811157D1
Authority
DE
Germany
Prior art keywords
psa
act
antibody reagent
microparticles
washed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69811157T
Other languages
English (en)
Other versions
DE69811157T2 (de
Inventor
Zeqi Zhou
William Jeffrey Allard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25418024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69811157(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of DE69811157D1 publication Critical patent/DE69811157D1/de
Publication of DE69811157T2 publication Critical patent/DE69811157T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69811157T 1997-07-31 1998-07-17 Immunoassay zur Bestimmung von PSA-ACT Revoked DE69811157T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90374997A 1997-07-31 1997-07-31

Publications (2)

Publication Number Publication Date
DE69811157D1 true DE69811157D1 (de) 2003-03-13
DE69811157T2 DE69811157T2 (de) 2003-07-24

Family

ID=25418024

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811157T Revoked DE69811157T2 (de) 1997-07-31 1998-07-17 Immunoassay zur Bestimmung von PSA-ACT

Country Status (6)

Country Link
EP (1) EP0895085B1 (de)
JP (1) JPH11118804A (de)
AT (1) ATE232299T1 (de)
CA (1) CA2243033A1 (de)
DE (1) DE69811157T2 (de)
ES (1) ES2191889T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781669B2 (en) * 1999-10-07 2005-06-02 Joken Limited Detection of prostate cancer measuring PSA/IGF-1 ratio
JP2004510161A (ja) * 2000-09-25 2004-04-02 アボット・ラボラトリーズ 高分子ポリカチオンを用いることにより、特異的結合アッセイにおける血清または血漿含有アッセイ試料の干渉を減少させるための方法及びキット
CN106198989B (zh) * 2016-06-29 2018-02-16 丹娜（天津）生物科技有限公司 检测前列腺特异抗原与α1‑抗糜蛋白酶复合物的试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4322342A1 (de) * 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
IL121659A (en) * 1996-10-25 2000-07-16 Bayer Ag Method for determining CPSA in a blood sample
US5856182A (en) * 1996-11-18 1999-01-05 Beckman Coulter, Inc. Monoclonal antibodies specific for the PSA-ACT complex

Also Published As

Publication number Publication date
ATE232299T1 (de) 2003-02-15
EP0895085A1 (de) 1999-02-03
DE69811157T2 (de) 2003-07-24
EP0895085B1 (de) 2003-02-05
JPH11118804A (ja) 1999-04-30
CA2243033A1 (en) 1999-01-31
ES2191889T3 (es) 2003-09-16

Similar Documents

Publication Publication Date Title
NO974534L (no) Bestemmelse av cPSA
RU2003133925A (ru) Способ дифференциальной диагностики деменции альцгеймера и устройство для его проведения
BR9916407A (pt) Detecção e tratamento de doenças dos rins
CN1271417A (zh) 对生物样品中的分析物进行快速分析的方法和设备
CN203405464U (zh) 定量检测胃蛋白酶原ii的时间分辨免疫层析试纸条及使用其的试纸卡
WO2011074802A2 (ko) 전립선암 진단용 키트 및 진단방법
DE69941627D1 (de) Für krebs
AU2009314258B2 (en) Thyroid analyte detection and measurement
KR100394940B1 (ko) 간 질환 진단을 위한 혈중 아사이알로당단백질양의측정방법 및 측정용 킷트
Salama et al. Chemiluminescent optical fiber immunosensor for detection of autoantibodies to ovarian and breast cancer-associated antigens
DE69811157D1 (de) Immunoassay zur Bestimmung von PSA-ACT
ATE378601T1 (de) Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
KR101138343B1 (ko) 알츠하이머 질병의 진단을 위한 신속한 시험법
Wymenga et al. Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasis
CN208537565U (zh) C-反应蛋白、血清淀粉样蛋白a免疫层析定量联合检测试纸条
US20200225220A1 (en) Lateral flow test strip assay for osteoporosis
CN204287198U (zh) 全程c-反应蛋白免疫层析定量检测试纸条
DE59602091D1 (de) Verwendung von polyklonalen humanen anti-htg-autoantikörpern als reagenz für die klinische diagnostik von schilddrüsen-autoimmunerkrankungen sowie reagenziensatz für eine bestimmung von anti-htg-autoantikörpern in patientenseren
JP4633510B2 (ja) 免疫学的クロマトグラフ法を用いた複数の試験紙片の短時間連続定量測定装置
BR9908669A (pt) Sistema de diagnóstico automático implementando análise imunológica e análise quìmica de acordo com algorìtimo reflexo
Maeda et al. Direct solid-phase time-resolved fluoroimmunoassay of 17α-hydroxyprogesterone in dried blood spotted on filter paper
JP2003130871A (ja) タンパク量の測定法
KR20240063883A (ko) 반려동물에서의 바이오마커 검출의 방법
WO2023230584A1 (en) Methods and systems for risk stratification and management of bladder cancer
WO1998015836A1 (en) Assay for determining anti-endomysial antibodies

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation